Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposing. (2023)
Attributed to:
MICA: Treatment According to Response in Giant cEll arTeritis (TARGET)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/ard-2022-223697
PubMed Identifier: 36797040
Publication URI: http://europepmc.org/abstract/MED/36797040
Type: Journal Article/Review
Volume: 82
Parent Publication: Annals of the rheumatic diseases
Issue: 6
ISSN: 0003-4967